- The bicalutamide 150 mg early prostate cancer program: findings of the north american trial at 7.7-year median followup. McLeod, D.G., See, W.A., Klimberg, I., Gleason, D., Chodak, G., Montie, J., Bernstein, G., Morris, C., Armstrong, J. J. Urol. (2006)